These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
837 related articles for article (PubMed ID: 16339681)
1. Transfusion safety: Where are we today? Luban NL Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681 [TBL] [Abstract][Full Text] [Related]
2. Current risks in blood transfusion in Japan. Otsubo H; Yamaguchi K Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347 [TBL] [Abstract][Full Text] [Related]
3. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes. Corash L Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276 [TBL] [Abstract][Full Text] [Related]
9. Reacting to an emerging safety threat: West Nile virus in North America. Stramer SL Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880 [TBL] [Abstract][Full Text] [Related]
10. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Blajchman MA Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252 [TBL] [Abstract][Full Text] [Related]
12. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States. Vamvakas EC; Kleinman S; Hume H; Sher GD Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024 [TBL] [Abstract][Full Text] [Related]
13. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350 [TBL] [Abstract][Full Text] [Related]
14. Alternative strategies in assuring blood safety: An overview. Epstein JS Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174 [TBL] [Abstract][Full Text] [Related]
15. European strategies against the parasite transfusion risk. Reesink HW Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284 [TBL] [Abstract][Full Text] [Related]
17. Safety of the blood supply. Sloand EM; Pitt E; Klein HG JAMA; 1995 Nov; 274(17):1368-73. PubMed ID: 7563562 [No Abstract] [Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
19. Approaches to minimize infection risk in blood banking and transfusion practice. Lindholm PF; Annen K; Ramsey G Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341 [TBL] [Abstract][Full Text] [Related]
20. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Eder A; Goldman M; Rossmann S; Waxman D; Bianco C Transfus Med Rev; 2009 Jul; 23(3):205-20. PubMed ID: 19539875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]